| Literature DB >> 22230609 |
Yang Li1, Xinying Wang, Ning Li, Jieshou Li.
Abstract
BACKGROUND: Hemorrhagic shock followed by resuscitation stimulates an inflammatory response. This study tests the hypothesis that treatment with fish oil will attenuate inflammatory responses and stabilize hemodynamics.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22230609 PMCID: PMC3281780 DOI: 10.1186/1476-511X-11-5
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Volumes of Blood Withdrawn of the Induction and Maintenance of Shock, Fluids Given, and Urines During Resuscitation(Median ± SE)
| Volume loss for induction to shock | - | 9.97 ± 0.22 | 10.19 ± 0.92 | 10.23 ± 0.45 | 0.742 |
| Volume loss for maintenance of shock | 11.53 ± 0.46 | 11.57 ± 1.13 | 12.43 ± 0.84 | 0.187 | |
| Ringer's solution (mL) | 4.80 ± 0.59 | 4.05 ± 0.89 | 0.001 | ||
| Urines (mL) | 0.93 ± 0.11 | 0.14 ± 0.22* | 0.65 ± 0.19* | 0.87 ± 0.21 | 0.001 |
independent samples t-test used in Ringer's solution; ANOVA p* < 0.001 vs. corresponding FO group
Figure 1Time of cost of mean arterial pressure(MAP)during shock and resuscitation. Sham group remained at baseline; shock, HS/R, FO groups' MAP fell to 35-40 mmHg for 60 minutes. HS/R and FO groups recovered to baseline during resuscitation and declined gradually without intervention.
After resuscitation, the MAP of sham group, resuscitation group and FO group in four different time points
| 105 min | 121.75 ± 8.54 | 109.00 ± 2.16 | 109.8 ± 2.17 | 0.36 |
| 155 min | 122.25 ± 6.08* | 76.5 ± 2.08* | 96 ± 7.07 | 0.001 |
| 210 min | 116.25 ± 4.86* | 72.5 ± 2.88* | 91.10 ± 1.41 | 0.001 |
| 345 min | 123.00 ± 7.12* | 63.75 ± 0.957* | 87.05 ± 3.40 | 0.001 |
| 0.504 | 0.001 | 0.11 | ||
p* < 0.001 vs. corresponding FO group; p
Mean Concentrations ± SE of the of Various Oxidative and Inflammatory Molecules
| TNF-α (pg/mL) | 59.53 ± 15.02 | 197.59 ± 18.33* | 222.02 ± 13.21* | 243.0 ± 10.2* | 42.00 ± 1.08 | 197.59 ± 18.33* # | 66.07 ± 9.03 | 43.31 ± 0.084 |
| IL-6 (pg/mL) | 21.71 ± 0.78 | 84.80 ± 5.66* # | 122.01 ± 24.72* # | 22.26 ± 2.35 | 22.80 ± 1.06 | 84.80 ± 5.66* | 122.85 ± 31.23* # | 54.89 ± 5.22 |
| Endotoxin(EU/mL) | 0.22 ± 0.009 | 0.87 ± 0.056* # | 1.26 ± 0.116* # | 0.24 ± 0.016 | 0.29 ± 0.046 | 0.87 ± 0.056* # | 3.60 ± 0.358* # | 2.58 ± 0.24* |
| Total GSH (μmol/L) | 703.75 ± 9.64 | 741.10 ± 31.76 | 714.96 ± 23.40 | 719.47 ± 13.0 | 680.77 ± 31.9 | 741.1 ± 31.77 | 719.47 ± 16.65 | 717.1 ± 16.89 |
| Reduced-GSH (μmol/L) | 273.71 ± 15.4 | 259.00 ± 5.83 | 255.91 ± 3.87 | 262.84 ± 21.2 | 283.31 ± 8.02 | 259.00 ± 5.83 | 254.33 ± 8.14 | 269.42 ± 3.48 |
| Reduced/total GSH | 0.78 ± 0.047 | 0.70 ± 0.033 | 0.72 ± 0.013 | 0.73 ± 0.06 | 0.81 ± 0.073 | 0.70 ± 0.033 | 0.70 ± 0.033 | 0.75 ± 0.060 |
| MDA (μmol/L) | 15.72 ± 11.59 | 43.91 ± 1.96* # | 52.55 ± 5.22* # | 27.78 ± 4.54* | 12.32 ± 5.16 | 43.91 ± 1.96* # | 59.67 ± 12.87* # | 17.55 ± 5.14 |
| MPO(μmol/L) | 26.55 ± 3.61 | 199.11 ± 18.06* # | 257.74 ± 12.18* # | 172.5 ± 58.3* | 27.50 ± 8.08 | 199.11 ± 18.06* # | 356.93 ± 9.21* # | 61.95 ± 6.26 |
* P < 0.01 vs sham group (1-way ANOVA); shock and resuscitation group vs FO group